
While the world is still reeling from the US presidential election results; it’s business as usual for the pharma industry; …

This week has seen pharmaceutical companies defending their patent protections and host of new collaboration spring up between companies. Read …

This week has seen pharmaceutical companies release their third quarter profits, good news for some whilst others have attempted to …

Halloween is creeping up, and its business as usual for the pharma industry; the week has been full of shockers, …

This week has seen a lot of news regarding specific drugs going through trial and some impressive results within. Read …

It’s Friday (and print day for the Pharmafocus October edition!) and its been a pretty explosive week, from new and …

As Mylan is left reeling from the backlash on its EpiPen price increase in the US, many lost their jobs …

The end of another week, and from huge expansions and investments to some shocking and saddening tragedies, it’s been a …

It’s Friday, and we’ve seen some big developments in the industry’s headlines throughout the week, from news of Glaxo-Smith-Kilne’s new …